| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |